These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
166 related articles for article (PubMed ID: 9018439)
21. Syngeneic central nervous system transplantation of genetically transduced mature, adult astrocytes. Selkirk SM; Greenberg SJ; Plunkett RJ; Barone TA; Lis A; Spence PO Gene Ther; 2002 Apr; 9(7):432-43. PubMed ID: 11938458 [TBL] [Abstract][Full Text] [Related]
22. Central nervous system delivery of recombinant ciliary neurotrophic factor by polymer encapsulated differentiated C2C12 myoblasts. Déglon N; Heyd B; Tan SA; Joseph JM; Zurn AD; Aebischer P Hum Gene Ther; 1996 Nov; 7(17):2135-46. PubMed ID: 8934227 [TBL] [Abstract][Full Text] [Related]
23. The therapeutic use of gene therapy in inflammatory demyelinating diseases of the central nervous system. Furlan R; Pluchino S; Martino G Curr Opin Neurol; 2003 Jun; 16(3):385-92. PubMed ID: 12858077 [TBL] [Abstract][Full Text] [Related]
24. Viral-Mediated Gene Replacement Therapy in the Developing Central Nervous System: Current Status and Future Directions. Uchitel J; Kantor B; Smith EC; Mikati MA Pediatr Neurol; 2020 Sep; 110():5-19. PubMed ID: 32684374 [TBL] [Abstract][Full Text] [Related]
25. Critical issues in gene therapy for neurologic disease. Hsich G; Sena-Esteves M; Breakefield XO Hum Gene Ther; 2002 Mar; 13(5):579-604. PubMed ID: 11916483 [TBL] [Abstract][Full Text] [Related]
28. Human fetal astrocytes as an ex vivo gene therapy vehicle for delivering biologically active nerve growth factor. Lin Q; Cunningham LA; Epstein LG; Pechan PA; Short MP; Fleet C; Bohn MC Hum Gene Ther; 1997 Feb; 8(3):331-9. PubMed ID: 9048200 [TBL] [Abstract][Full Text] [Related]
29. HSV vector-mediated gene delivery to the central nervous system. Maguire-Zeiss KA; Bowers WJ; Federoff HJ Curr Opin Mol Ther; 2001 Oct; 3(5):482-90. PubMed ID: 11699893 [TBL] [Abstract][Full Text] [Related]
30. Gene therapy for the CNS using AAVs: The impact of systemic delivery by AAV9. Saraiva J; Nobre RJ; Pereira de Almeida L J Control Release; 2016 Nov; 241():94-109. PubMed ID: 27637390 [TBL] [Abstract][Full Text] [Related]
31. Gene therapy for the nervous system: challenges and new strategies. Maguire CA; Ramirez SH; Merkel SF; Sena-Esteves M; Breakefield XO Neurotherapeutics; 2014 Oct; 11(4):817-39. PubMed ID: 25159276 [TBL] [Abstract][Full Text] [Related]
32. Towards gene therapy for the central nervous system. During MJ; Ashenden LM Mol Med Today; 1998 Nov; 4(11):485-93. PubMed ID: 9857368 [TBL] [Abstract][Full Text] [Related]
33. Defective viral vectors as agents for gene transfer in the nervous system. Kaplitt MG; Makimura H J Neurosci Methods; 1997 Jan; 71(1):125-32. PubMed ID: 9125381 [TBL] [Abstract][Full Text] [Related]
34. Invasive drug delivery. Blömer U; Ganser A; Scherr M Adv Exp Med Biol; 2002; 513():431-51. PubMed ID: 12575831 [TBL] [Abstract][Full Text] [Related]
35. Crossing the blood-brain-barrier with viral vectors. Fu H; McCarty DM Curr Opin Virol; 2016 Dec; 21():87-92. PubMed ID: 27591676 [TBL] [Abstract][Full Text] [Related]
36. Neural stem cells -- a versatile tool for cell replacement and gene therapy in the central nervous system. Ourednik V; Ourednik J; Park KI; Snyder EY Clin Genet; 1999 Oct; 56(4):267-78. PubMed ID: 10636444 [TBL] [Abstract][Full Text] [Related]